Jacqueline Q T Kwan
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Jacqueline Q T Kwan has a total of 13 co-authors. Here are the top co-authors by number of shared publications:
Christina Erwin
Academic Program in Obstetrics and Gynaecology, Duke-NUS Medical School, Singapore
2 shared publications- Durai Shivani
Department of Obstetrics and Gynaecology, KK Women's and Children's Hospital, Singapore
2 shared publications - Jerry Kok Yen Chan
Department of Reproductive Medicine, KK Women’s and Children’s Hospital, Singapore, Singapore
2 shared publications - Karrie Kwan Ki Ko
Department of Microbiology, Singapore General Hospital, Singapore, Singapore
2 shared publications Lynette Oon
Department of Molecular Pathology, Singapore General Hospital, Singapore
2 shared publications- Shirin Kalimuddin
Programme in Emerging Infectious Diseases, Duke-NUS Medical School, Singapore, Singapore
2 shared publications
Latest Publications
- Open Access
- 1 March 2021
- Published by Elsevier in International Journal of Infectious Diseases
- Vol. 104, 255-261
Validation of self-collected buccal swab and saliva as a diagnostic tool for COVID-19
- 1 March 2021
- Published by Elsevier in International Journal of Infectious Diseases
- Vol. 104, 255-261
Open AccessValidation of self-collected buccal swab and saliva as a diagnostic tool for COVID-19
- Open Access
Validation of self-collected buccal swab and saliva as a diagnostic tool for COVID-19
Background: Effective management of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) requires large-scale testing. Collection of nasopharyngeal swab (NPS) by healthcare workers (HCW) is currently used to diagnose SARS-CoV-2, which increases the risk of transmission to HCWs. Self-administered saliva and buccal swabs are convenient, painless and safe alternative sample collection methods. Methods: A cross-sectional single centre study was conducted on 42 participants who were tested positive for SARS-CoV-2 via NPS within the past 7 days. A self-collected saliva and buccal swab and a HCW-collected NPS were obtained. Real-time polymerase chain reaction (RT-PCR) was performed and cycle threshold (CT) values were obtained. Positive percent agreement (PPA), negative percent agreement (NPA) and overall agreement (OA) were calculated for saliva and buccal swabs, as compared with NPS. Results: Among the 42 participants, 73.8% (31/42) tested positive via any one of the 3 tests. With reference to NPS, the saliva test had PPA 66.7%, NPA 91.7% and OA 69.0%. The buccal swab had PPA 56.7%, NPA 100% and OA 73.8%. Presence of symptoms improved diagnostic accuracy. There was no statistically significant association between CT values and duration of symptom onset within the first 12 days of symptoms for all three modalities. Conclusion: Self-collected saliva tests and buccal swabs have only moderate agreement with HCW-collected NPS swabs. Primary screening for SARS-CoV-2 may be performed with a saliva test or buccal swab, with a negative test warranting a confirmatory NPS to avoid false negatives. This combined strategy minimizes discomfort and reduces the risk of spread to the community and HCWs.
Open AccessValidation of self-collected buccal swab and saliva as a diagnostic tool for COVID-19
Background: Effective management of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) requires large-scale testing. Collection of nasopharyngeal swab (NPS) by healthcare workers (HCW) is currently used to diagnose SARS-CoV-2, which increases the risk of transmission to HCWs. Self-administered saliva and buccal swabs are convenient, painless and safe alternative sample collection methods. Methods: A cross-sectional single centre study was conducted on 42 participants who were tested positive for SARS-CoV-2 via NPS within the past 7 days. A self-collected saliva and buccal swab and a HCW-collected NPS were obtained. Real-time polymerase chain reaction (RT-PCR) was performed and cycle threshold (CT) values were obtained. Positive percent agreement (PPA), negative percent agreement (NPA) and overall agreement (OA) were calculated for saliva and buccal swabs, as compared with NPS. Results: Among the 42 participants, 73.8% (31/42) tested positive via any one of the 3 tests. With reference to NPS, the saliva test had PPA 66.7%, NPA 91.7% and OA 69.0%. The buccal swab had PPA 56.7%, NPA 100% and OA 73.8%. Presence of symptoms improved diagnostic accuracy. There was no statistically significant association between CT values and duration of symptom onset within the first 12 days of symptoms for all three modalities. Conclusion: Self-collected saliva tests and buccal swabs have only moderate agreement with HCW-collected NPS swabs. Primary screening for SARS-CoV-2 may be performed with a saliva test or buccal swab, with a negative test warranting a confirmatory NPS to avoid false negatives. This combined strategy minimizes discomfort and reduces the risk of spread to the community and HCWs.